BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23832923)

  • 1. Medication safety: opening up the black box.
    Mintzes B
    BMJ Qual Saf; 2013 Sep; 22(9):702-4. PubMed ID: 23832923
    [No Abstract]   [Full Text] [Related]  

  • 2. Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs.
    Kesselheim AS; Franklin JM; Avorn J; Duke JD
    BMJ Qual Saf; 2013 Sep; 22(9):727-34. PubMed ID: 23620531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 4. Over-the-counter product line extensions: have we reached the limit yet?
    Sansgiry SS
    J Am Geriatr Soc; 2004 Jul; 52(7):1223-4. PubMed ID: 15209675
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacists and patients feedback on empirically designed prescription warning labels: a qualitative study.
    Shiyanbola OO; Smith PD; Huang YM; Mansukhani SG
    Int J Clin Pharm; 2017 Feb; 39(1):187-195. PubMed ID: 28070688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Product information past perfect.
    Dowden JS
    Med J Aust; 2007 Jan; 186(2):51-2. PubMed ID: 17223760
    [No Abstract]   [Full Text] [Related]  

  • 7. An open letter on line extensions.
    Krogh C
    Dimens Health Serv; 1990 Nov; 67(8):5. PubMed ID: 2276526
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 9. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract]   [Full Text] [Related]  

  • 10. Advancing Best Practices for Prescription Drug Labeling.
    Bailey SC; Navaratnam P; Black H; Russell AL; Wolf MS
    Ann Pharmacother; 2015 Nov; 49(11):1222-36. PubMed ID: 26354048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIMS is not a stand-alone resource.
    Donohoo EA
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484718
    [No Abstract]   [Full Text] [Related]  

  • 12. The National Prescribing Service should lead.
    Stockigt JR
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484717
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicines and breastfeeding: information is available on safe use.
    Amir LH
    Med J Aust; 2007 May; 186(9):485. PubMed ID: 17484719
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs and Diseases Interacting with Cigarette Smoking in US Prescription Drug Labelling.
    Li H; Shi Q
    Clin Pharmacokinet; 2015 May; 54(5):493-501. PubMed ID: 25701380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encouraging pharmacist intervention and standardization of labeling and dispensing of oral liquid medications.
    Endriukaitis LA; Briars LA; Bursua AJ
    J Am Pharm Assoc (2003); 2017; 57(3):412-413. PubMed ID: 28506399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New (still proposed) rules for sunscreen. UVA testing and ranking may be the most important change.
    Harv Health Lett; 2010 Jun; 35(8):6. PubMed ID: 20700956
    [No Abstract]   [Full Text] [Related]  

  • 17. Era of faster FDA drug approval has also seen increased black-box warnings and market withdrawals.
    Frank C; Himmelstein DU; Woolhandler S; Bor DH; Wolfe SM; Heymann O; Zallman L; Lasser KE
    Health Aff (Millwood); 2014 Aug; 33(8):1453-9. PubMed ID: 25092848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
    Davis JJ
    J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug names: when marketing and safety collide.
    Rupp MT; Parker JM
    Am Pharm; 1993 May; NS33(5):39-42. PubMed ID: 8333406
    [No Abstract]   [Full Text] [Related]  

  • 20. Discrepancies in the Evidence and Recommendation Levels of Pregnancy Information in Prescription Drug Labeling in the United States, United Kingdom, Japan, and Korea.
    Noh Y; Yoon D; Song I; Jeong HE; Bae JH; Shin JY
    J Womens Health (Larchmt); 2018 Sep; 27(9):1086-1092. PubMed ID: 29878862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.